glp 1 body composition Lean mass loss on GLP-1 receptor agonists: a downside of the “miracle drugs” GLP-1 Drugs and Body Composition:

Researchers investigating metabolic syndrome and HIV-associated lipodystrophy have observed measurable VAT reduction without comparable losses in subcutaneous fat, suggesting depot-specific selectivity

Inhibition of GST A3-3 in progesterone-producing human cells suppress the formation of the hormone

They include blocking the formation of reactive oxygen and carbonyl species, detoxifying toxic products of lipid peroxidation such as acrolein, protecting keratinocytes from lethal UVB radiation, and blocking hepatic damage by dichloromethane radicals

[57] This activation reduces the production of reactive oxygen species (ROS) and mitigates endoplasmic reticulum (ER) stress